BT3:FRA
Lineage Cell Therapeutics Inc
€0,82
arrow_upward
+1,23%(+0,0100) 1 HR
8 Okt, 22.00.00 GMT+2 · EUR
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk BT3...
Pembukaan
€0,82
Tinggi
€0,82
Rendah
€0,82
Kapitalisasi pasar
259,91Â jt
Volume rata-rata
37,00
Volume
0,00
Harga tinggi dalam 52 minggu terakhir
€1,69
Harga rendah dalam 52 minggu terakhir
€0,78
Jumlah karyawan
75
Pembukaan
€0,82
Tinggi
€0,82
Rendah
€0,82
Kapitalisasi pasar
259,91Â jt
Volume rata-rata
37,00
Volume
0,00
Harga tinggi dalam 52 minggu terakhir
€1,69
Harga rendah dalam 52 minggu terakhir
€0,78
Jumlah karyawan
75
Artikel berita
Dari sumber web dan partner berita
XTB.com
·
2 hari yang lalu
S&P 500 Dekati Rekor, Earnings Tetap Kuat
XTB.com
·
1 hari yang lalu
S&P 500 Rekor Baru, Earnings Jadi Fokus Pasar
BeInCrypto
·
9 jam yang lalu
Prediksi S&P 500 Paling Bearish di Wall Street Bergantung pada Satu Sinyal Grafik
Vietnam.vn
·
1 hari yang lalu
AI terus mendorong Nasdaq ke level tertinggi sepanjang masa.
Profil
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Tentang Lineage Cell Therapeutics Inc